Topics
- How Phase IV Studies may change
- The European requirements for reporting AEs/SAEs
- Risk based supply modelling
- Predictive event modelling in Oncology trials
- Software tools, case studies and implementation
Who should Attend
VPs, Heads of Research and Executive Medical Directors, Development, Heads, Senior Directors, Managers and Directors of:
- Clinical Development
- Clinical Operations
- Clinical Scientists
- Clinical Research Directors
- Medical Scientific Experts
- Medical Experts
- Medicla Affairs
